DUBLIN, October 21, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Cardiovascular Surgical Devices: Technologies and Global Markets" report to their offering.
The global market for cardiovascular surgical devices is expected to grow from nearly $37.0 billion in 2015 to $57.2 billion in 2020 at a compound annual growth rate of 9.4% from 2015-2020.
The scope of this study encompasses multiple technologies and procedures related to cardiovascular surgical devices. The study focused primarily on four categories of cardiovascular surgery: traditional (open), interventional, cardiac rhythm management (CRM) and cardiac ablation procedures. These procedure groupings are categorized logically so that comparisons can be made within procedural groups as well as across the cardiovascular surgical devices industry as a whole. Note that carotid artery surgery related to stroke, abdominal aortic aneurysm (AAA) surgery to correct aortic aneurysms, and surgical and stenting procedures designed to address peripheral vascular disease are not addressed in detail in this report.
The industry is analyzed on a worldwide basis from market, product and technology perspectives. Regulations and reimbursement issues and patents issued from 2011 through mid-2016 are also examined to identify patient safety, regulatory review and insurance coverage issues for stakeholders and potential stakeholders in this industry.
The report examines the cardiovascular surgery device industry in general, the types of technologies currently in use as well as future technological developments, and regulatory influences that affect product distribution. The industry structure section discusses the most active manufacturers with respect to relative market share, marketing strengths and forces that promote or hinder the growth of technologies. The technology sections detail historical (2014), and projected (2015 to 2020) market values
Key Topics Covered:
1: Introduction
2: Summary
3: Implementation Of It In Cardiovascular Surgeries And Devices
4: Overview Of Cardiovascular Disease And Cardiovascular Surgery
5: Global Implications Of Cardiovascular Disease And Availability Of Cardiovascular Surgery
6: Global Markets For Traditional Cardiovascular Surgery Devices
7: Global Markets For Interventional Cardiovascular Surgery Devices
8: Global Market For Cardiac Rhythm Management Devices
9: Global Market For Cardiac Ablation Systems And Other Emerging Therapies
10: Industry Consolidation, U.S. Reimbursement Changes And Trends In Medical Device Industry Regulation
11: U.S. Patent Analysis Of Cardiovascular Devices
12: Company Profiles
- Abbott Vascular
- Abiomed Inc.
- Atricure Inc.
- Biosensors International
- Biotronik Inc., Div. Biotronik Se & Co Kg
- Bioventrix Inc.
- Boston Scientific Corp.
- C. R. Bard Inc.
- Cardiacassist Inc.(Tandemlife)
- Circulite Inc.
- Cordis Corp.
- Corindus Vascular Robotics
- Cryolife Inc.
- Cvrx Inc.
- Edwards Lifesciences Corp.
- Heartware International Inc.
- Intuitive Surgical
- Jarvik Heart Inc.
- Maquet Cardiovascular Llc
- Medtronic Corp.
- Merit Medical Systems Inc.
- On-X Life Technologies Inc.
- Orbusneich
- Qvanteq Ag
- St. Jude Medical Inc.
- Sorin Group Spa
- Spectranetics Corp.
- Sunshine Heart Inc.
- Syncardia Systems Inc.
- Terumo Cardiovascular Systems
- Thoratec Corp.
- Volcano Corp.
For more information about this report visit http://www.researchandmarkets.com/research/bzpzrq/cardiovascular
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
